COGNICURRENT

Researchers at Stanford Medicine have developed a nasal spray vaccine that offers potential protection against COVID-19, influenza, and pneumonia.

The WA government has introduced a $140 million plan to enhance healthcare capacity and vaccine initiatives to prevent a recurrence of last year's severe flu season.

Scientists are making significant progress towards a universal vaccine that could protect against colds, flu, COVID-19, and even allergies.

US scientists have developed a universal vaccine that could provide long-term immunity against coughs, colds, flu, and even some allergens.

Moderna has announced that the FDA has reversed its decision and will analyze its new flu vaccine, which uses mRNA technology.

Scientists have developed a universal vaccine that shows promise for protection against multiple respiratory infections and allergies, based on research conducted in mice.

Western Australians aged 65 and older living in residential aged care will receive free RSV vaccinations following a severe flu season, with the program expected to significantly improve health outcomes for vulnerable populations.

The FDA has decided to review Moderna's application for its mRNA-based flu vaccine after initially declining it, responding to criticism regarding its decision-making processes.

The FDA initially rejected Moderna's application for a new flu vaccine but has since agreed to review it based on new regulatory pathways for older adults following a constructive meeting.

The FDA declined to review Moderna's mRNA flu vaccine application, prompting concerns that the decision may be influenced by anti-vaccine sentiment rather than scientific rigor.

The flu virus has mutated, resulting in a significantly decreased effectiveness of the vaccine.

Virus expert Thea Kølsen Fischer debunks a common myth about flu vaccinations while also sharing personal precautions.

Moderna asserts that the US FDA has declined to review its mRNA-based flu vaccine due to concerns over inadequate clinical trials and lack of proper comparison with existing products.

The FDA has declined to review Moderna's mRNA flu vaccine application, potentially delaying its introduction for older adults.

US regulators have refused to review Moderna's request for a new flu vaccine, raising concerns about the future of flu vaccination efforts in the country.

Virus doctor Thea Kølsen Fischer shares her views on vaccines and health practices, emphasizing hygiene and debunking misconceptions about vaccine side effects.

The Queensland government is continuing its free flu vaccination program, introducing a needle-free nasal spray option for young children aged two to five to ease vaccine administration.

Over 90,000 doses of the flu vaccine in São Paulo's health posts are being discarded despite still being valid due to regulations from the National Health Surveillance Agency (Anvisa).

The Chilean government has contracted Chinese company Sinovac to provide flu vaccines for its nationwide immunization campaign starting in March, marking the second consecutive year of collaboration.

Greek Health Minister Georgiadis urges the public to get vaccinated against the flu, emphasizing the strain on emergency services from unvaccinated individuals amid the vaccine's long history of safety.

Hospitals in the Gaza Strip are warning of shortages of vaccines and medications amidst a rise in illnesses related to winter, with concerns specifically about flu vaccines and asthma treatments.